This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Uraemic pruritus

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Itch (uraemic pruritus) is a common symptom in people with endstage kidney disease (ESKD)

  • affects 42% to 57% of people on dialysis

Despite its high prevalence, mechanisms driving uraemic itch remain poorly understood

  • two common theories implicate hyperactive and disordered immune or opioid systems
    • roles have also been proposed for hyperparathyroidism, abnormal serum chemistry, mast cell hyperactivity, and dialysis technique

Management (1):

  • evidence that gabapentinoids (gabapentin and pregabalin) show the greatest reduction in itch scores
  • evidence for oral montelukast, turmeric, zinc sulfate, and topical capsaicin also showed an itch score reduction. However, these reductions
    were reported in small studies, and warrant further investigation

Reference

  • Hercz D et al.Interventions for itch in people with advanced chronic kidney disease. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No.: CD011393. DOI: 10.1002/14651858.CD011393.pub2.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.